ribavirin has been researched along with Grippe in 110 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 47 (42.73) | 18.7374 |
1990's | 11 (10.00) | 18.2507 |
2000's | 16 (14.55) | 29.6817 |
2010's | 29 (26.36) | 24.3611 |
2020's | 7 (6.36) | 2.80 |
Authors | Studies |
---|---|
De Clercq, E; Foscolos, GB; Fytas, G; Kolocouris, A; Kolocouris, N; Neyts, J; Padalko, E; Stylianakis, I | 1 |
Bailey, KW; Barnard, DL; Day, CW; Furuta, Y; Morrey, JD; Sidwell, RW; Smee, DF; Wong, MH | 1 |
Li, YH; Li, ZR; Liu, ZY; Shao, HY; Wang, B; Yi, H; You, XF; Zhao, LX | 1 |
Deyde, VM; Furuta, Y; Gubareva, LV; Klimov, AI; Mishin, VP; Sleeman, K | 1 |
Aisa, HA; Zhao, J | 1 |
Botta, M; de Esch, I; Deodato, D; Edink, E; Fallacara, AL; Gospodova, T; Loregian, A; Mercorelli, B; Nannetti, G; Palù, G; Tintori, C; Trist, IM; Verheij, M; Viteva, L; Wijtmans, M | 1 |
Cen, S; Fang, W; Guo, BL; Yang, YJ | 1 |
Aisa, HA; Li, G; Liu, GY; Lu, W; Obul, M; Zhao, JY | 1 |
Borisevich, SS; Lantseva, K; Mainagashev, IY; Salakhutdinov, NF; Shtro, AA; Sokolova, AS; Volobueva, AS; Yarovaya, OI; Zarubaev, VV | 1 |
Çapan, G; Cihan-Üstündağ, G; Naesens, L; Ozkirimli, E; Persoons, L; Vanderlinden, E; Zopun, M | 1 |
Borisevich, SS; Khomenko, TM; Kireeva, MV; Komarova, NI; Korchagina, DV; Salakhutdinov, NF; Slita, AV; Volcho, KP; Volobueva, AS; Zarubaev, VV | 1 |
Arzel, P; Chaltin, P; Klaassen, H; Marchand, A; Naesens, L; Persoons, L; Van Berwaer, R; van Dam, W; Vanderlinden, E | 1 |
Ding, YL; Hu, CC; Li, WF; Yuan, B | 1 |
Alffenaar, JC; de Zwart, AES; Kerstjens, HAM; Riezebos-Brilman, A; Verschuuren, EAM | 1 |
Chen, K; Couban, RJ; Du, X; Gong, X; Guyatt, G; He, N; Ibrahim, QI; Li, X; Li, Y; Liu, F; Liu, J; Liu, W; Shen, N; Tang, Q; Wu, Z; Xu, X; Ye, Z; Ying, Y; Zhai, S; Zhang, Q; Zhang, Y; Zhou, P | 1 |
Chen, W; Guan, M; Guo, Y; Ma, Y; Wang, Y; Zhang, H | 1 |
Bao, Y; Beasley, RL; Beeler, J; Beigel, JH; Bozzolo, DR; Dar, SM; Davey, RT; Holley, HP; Hoopes, J; Hughes, MD; Lane, HC; Losso, MH; Manosuthi, W; McClure, N; Myers, C; Panuto, J; Perez-Patrigeon, S; Slandzicki, A; Suwanpimolkul, G | 1 |
Choi, SH; Chong, YP; Do, KH; Hong, SB; Huh, JW; Jung, J; Kim, MJ; Kim, SH; Kim, YS; Koh, Y; Koo, HJ; Lee, SO; Lim, CM; Sung, H; Woo, JH | 1 |
Day, CW; Hurst, BL; Januszczyk, P; Krajczyk, A; Kulinska, K; Kulinski, T; Ostrowski, T; Smee, DF; Zeidler, J | 1 |
Deng, L; Jiang, L; Wu, T | 1 |
Jang, HC; Jung, SI; Kang, SJ; Kee, SJ; Kwon, YS; Park, KH; Shin, JH | 1 |
Boeckh, MJ; Chemaly, RF; Shah, DP | 1 |
Benschop, KS; Duizer, E; Koopmans, MP; van der Avoort, HG | 1 |
Fan, L; He, J; He, ZD; Hu, XP; Hu, YJ; Li, CY; Li, SH; Liao, CH; Qi, L; Shao, MM; Song, X; Wu, HQ; Wu, XL; Zhang, FX; Zhang, J; Zheng, K | 1 |
Dou, J; Jin, J; Li, M; Wang, D; Wang, H; Xu, J; Yu, J; Zhou, C | 1 |
Li, M; Liu, J; Ma, Y; Wang, Y; Zhang, W; Zhao, Z | 1 |
Berger, A; Christopeit, M; Hauf, E; Hentrich, M; Heussel, CP; Kalkreuth, J; Klein, M; Kochanek, M; Lehners, N; Mayer, K; Penack, O; Rieger, C; Schalk, E; Silling, G; Vehreschild, M; von Lilienfeld-Toal, M; Weber, T; Wolf, HH | 1 |
Gajda, P; Hinton, TM; Riber, CF; Stewart, C; Tolstrup, M; Zelikin, AN; Zuwala, K | 1 |
Ariza-Heredia, EJ; Chemaly, RF; Shahani, L | 1 |
Bi, Y; Cao, L; Gao, L; Han, J; Liu, J; Si, J; Sun, Y; Wang, H; Wang, J | 1 |
Clement, CG; Dickey, BF; Evans, SE; Gilbert, BE; Tuvim, MJ | 1 |
Theiler, RN | 1 |
Birnkrant, DB; Chan-Tack, KM; Murray, JS | 1 |
Ariano, RE; Smith, JR; Toovey, S | 1 |
Burke, JD; Fish, EN | 1 |
Drozdov, IG; Durymanov, AM; Leneva, IA; Romanovskaia, AA; Sharshov, KA; Shestopalov, AM; Susloparov, IM; Zaĭkovskaia, AV | 1 |
Furuta, Y; Kawaoka, Y; Kiso, M; Le, QM; Ozawa, M; Sakabe, S; Sakai-Tagawa, Y; Shinya, K; Takahashi, K | 1 |
Cheng, H; Geng, X; Han, X; Li, Z; Liu, C; Liu, L; Ma, Y; Ruan, S; Wang, C; Xu, H; Xu, S; Yang, G; Yu, Q; Zhang, J | 1 |
Tang, JW | 1 |
Deriabin, PG; Fediakina, IT; Gudova, NV; Kondrat'eva, TV; L'vov, DK; Leneva, IA; Shchelkanov, MIu | 1 |
Razonable, RR | 1 |
Choi, SH; Chon, GR; Han, MS; Hong, SB; Huh, JW; Kim, HR; Kim, MJ; Kim, SH; Kim, WY; Kim, YS; Ko, YG; Lee, KH; Ryu, YJ; Young Suh, G | 1 |
Buti, M; Esteban, R; Simón-Talero, M | 1 |
Boeckh, MJ; de Jong, MD; Englund, JA; Lindegardh, N; Nguyen, JT; Pukrittayakamee, S; Renaud, C; Seo, S; Tambyah, PA; Tarning, J; Went, GT | 1 |
Boas, LS; da Rocha, IF; Dulley, FL; Machado, CM; Mendes, AV; Pannuti, CS; Santos, MF; Sturaro, D | 1 |
Fediakina, IT; Glushkov, RG; Gus'kova, TA; Leneva, IA | 1 |
Mori, S; Shigeta, S; Yamamoto, N; Yamase, T | 1 |
Lynch, JP; Walsh, EE | 1 |
Chen, XY; Duan, X; Liu, GJ; Ni, J; Qiao, JQ; Wang, Q; Wei, J; Wu, TX; Zheng, J; Zhou, LK | 1 |
Gilbert, BE; McLeay, MT | 1 |
Cameron, RW; Couch, RB; Greggs, SE; Knight, V; McClung, HW; Quarles, JM; Waters, BK; Wilson, SZ; Zerwas, JM | 1 |
Feldblum, RL; Indulen, MK | 1 |
Nicholson, KG | 1 |
Jackson, GG | 1 |
Douglas, RG | 1 |
Divine, GW; Gilbert, BE; Knight, V; McClung, HW; Quarles, JM; Wilson, SZ | 1 |
Couch, RB; Gilbert, BE; Knight, V; McClung, HW; Moore, RV; Quarles, JM; Wilson, SZ | 1 |
Conner, CS | 1 |
Fedson, DS | 1 |
Boyd, MR; Browne, MJ; Moss, MY | 1 |
Charette, RP; Cooney, MK; Fox, JP; Hall, CE; Smith, CB | 1 |
Cote, KM; Douglas, RG; Hayden, FG | 1 |
Arrobio, J; Groothuis, JR; Hall, CB; Johnson, G; Rodriguez, WJ; Ryan, ME; Simoes, EA; Stutman, H; Van Dyke, R; Welliver, R | 1 |
Hayden, FG | 4 |
Andersson, J; Aschan, J; Ekelöf-Andström, E; Ljungman, P; Ringdén, O; Sparrelid, E; Wåhlin, B; Winiarski, J | 1 |
Bailey, KW; Barnard, DL; Huffman, JH; Kim, CU; Morrison, A; Sidwell, RW; Syndergaard, T; Wong, MH | 1 |
Mossad, SB | 1 |
Reina, J | 1 |
Connor, JD; Hayden, FG; Lane, J; Sable, CA | 1 |
Bessho, T; Ohyama, K; Uchide, N; Yamakawa, T; Yuan, B | 1 |
Luby, JP | 1 |
Chang, TW; Snydman, DR | 1 |
Briseno-Garcia, B; Nasser-Quinones, H; Salido-Rengell, F | 1 |
ter Meulen, V | 1 |
McCracken, EA; Togo, Y | 1 |
Cohen, A; Khakoo, R; Sigel, M; Togo, Y; Waldman, R | 1 |
Betts, RF; Douglas, RG; Magnussen, CR; Meagher, MP; Roth, FK | 1 |
Hermans, PE | 1 |
Couch, RB; Jackson, GG | 1 |
Oxford, JS | 1 |
Newell, PM; Van Voris, LP | 1 |
Connor, JD; Copeland, JG; Gaar, GG; Kramer, TH; Minnich, L; Ray, CG | 1 |
Gilbert, BE; Knight, V | 3 |
Bean, B | 1 |
Bryson, YJ | 1 |
Johnson, DC | 1 |
Andersson, J; Aschan, J; Forsgren, M; Lewensohn-Fuchs, I; Ljungman, P; Ringdén, O | 1 |
Bernstein, JM; Erk, SD; Liss, H | 1 |
Copeland, JG; Grogan, TM; Icenogle, TB; Minnich, LL; Ray, CG | 1 |
Bell, M; Hunter, JM; Mostafa, SM | 1 |
Amorico, MG; Baldini, EV; Bisetti, A; Pellegrino, M | 1 |
Dolin, R | 1 |
Banks, G; Fernandez, H; Smith, R | 1 |
Bernstein, DI; Reuman, PD; Schiff, GM; Sherwood, JR; Young, EC | 1 |
Bernstein, DI; Bernstein, JM; Creticos, CM; Hayden, FG; Jackson, GG; Schiff, GM; Stein, DS | 1 |
Carpenter, RJ; Faro, S; Kirshon, B; Samo, TC; Zurawin, RK | 1 |
Cockerill, FR; Hermans, PE | 1 |
Cates, KL | 1 |
Ahmed, ME; Branch, RA | 1 |
Couch, RB; Dure, L; Gilbert, BE; Hayes, N; Knight, V; Quarles, JM; Willis, G; Wilson, SZ | 1 |
Galbraith, AW | 1 |
Iakushin, AI; Trantseeva, TB | 1 |
30 review(s) available for ribavirin and Grippe
Article | Year |
---|---|
[Overview of Meta-analysis of Lianhua Qingwen preparations in treatment of viral diseases].
Topics: Cough; COVID-19 Drug Treatment; Drugs, Chinese Herbal; Fatigue; Fever; Humans; Influenza, Human; Meta-Analysis as Topic; Nonprescription Drugs; Nucleic Acids; Oseltamivir; Ribavirin | 2022 |
Efficacy and safety of antiviral treatment for COVID-19 from evidence in studies of SARS-CoV-2 and other acute viral infections: a systematic review and meta-analysis.
Topics: Amides; Antiviral Agents; Betacoronavirus; Chloroquine; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Evidence-Based Medicine; Humans; Hydroxychloroquine; Indoles; Influenza, Human; Lopinavir; Observational Studies as Topic; Pandemics; Pneumonia, Viral; Pyrazines; Ribavirin; Ritonavir; SARS-CoV-2 | 2020 |
Chinese medicinal herbs for influenza.
Topics: Amantadine; Antiviral Agents; Drugs, Chinese Herbal; Humans; Influenza, Human; Phytotherapy; Randomized Controlled Trials as Topic; Ribavirin | 2013 |
Management of respiratory viral infections in hematopoietic cell transplant recipients and patients with hematologic malignancies.
Topics: Antiviral Agents; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Influenza, Human; Paramyxoviridae Infections; Pneumonia, Viral; Recombinant Fusion Proteins; Respiratory Syncytial Virus Infections; Respiratory Tract Infections; Ribavirin; Virus Diseases | 2014 |
Antivirals against enteroviruses: a critical review from a public-health perspective.
Topics: Amantadine; Antiviral Agents; Child; Clinical Trials as Topic; Coinfection; Drug Resistance, Viral; Enterovirus; Enterovirus Infections; Epidemiological Monitoring; Hepatitis C; Humans; Immunocompromised Host; Influenza, Human; Public Health; Ribavirin | 2015 |
Community acquired respiratory virus infections in cancer patients-Guideline on diagnosis and management by the Infectious Diseases Working Party of the German Society for haematology and Medical Oncology.
Topics: Adenovirus Infections, Human; Antiviral Agents; Cidofovir; Community-Acquired Infections; Cytosine; Germany; Hand Hygiene; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Influenza, Human; Lung; Masks; Medical Oncology; Metapneumovirus; Neoplasms; Neuraminidase; Nucleic Acid Amplification Techniques; Organophosphonates; Oseltamivir; Paramyxoviridae Infections; Patient Isolation; Pneumonia, Viral; Respiratory Syncytial Virus Infections; Respiratory Tract Infections; Ribavirin; Tomography, X-Ray Computed; Virus Diseases | 2016 |
Antiviral therapy for respiratory viral infections in immunocompromised patients.
Topics: Acids, Carbocyclic; Amantadine; Antiviral Agents; Coronavirus Infections; Cyclopentanes; Guanidines; Humans; Immunocompromised Host; Influenza, Human; Oseltamivir; Palivizumab; Paramyxoviridae Infections; Picornaviridae Infections; Respiratory Syncytial Virus Infections; Respiratory Tract Infections; Ribavirin; Zanamivir | 2017 |
The use of antiviral agents for the management of severe influenza.
Topics: Age Factors; Antiviral Agents; Drug Therapy, Combination; Humans; Immunocompromised Host; Influenza A Virus, H1N1 Subtype; Influenza, Human; Interferons; Length of Stay; Neuraminidase; Oseltamivir; Practice Guidelines as Topic; Ribavirin; Risk Factors; Viral Load; Zanamivir | 2010 |
Antiviral strategies: the present and beyond.
Topics: Antiviral Agents; Drug Therapy, Combination; Hepatitis C, Chronic; Humans; Influenza, Human; Interferon-alpha; Oseltamivir; Ribavirin; Structure-Activity Relationship | 2009 |
Antiviral drugs for viruses other than human immunodeficiency virus.
Topics: Acyclovir; Adenine; Amantadine; Antiviral Agents; Comorbidity; Drug Therapy, Combination; Foscarnet; Ganciclovir; Guanine; Hepatitis; Hepatitis B, Chronic; Hepatitis C; Herpesviridae Infections; HIV Infections; Humans; Influenza, Human; Interferons; Lamivudine; Nucleosides; Oligopeptides; Organophosphonates; Oseltamivir; Proline; Protease Inhibitors; Pyrimidinones; Ribavirin; Telbivudine; Thymidine; Valacyclovir; Valganciclovir; Valine; Virus Replication; Zanamivir | 2011 |
Influenza: evolving strategies in treatment and prevention.
Topics: Aged; Amantadine; Antiviral Agents; Centers for Disease Control and Prevention, U.S.; Child, Preschool; Humans; Infant; Influenza A virus; Influenza B virus; Influenza Vaccines; Influenza, Human; Oseltamivir; Practice Guidelines as Topic; Ribavirin; Rimantadine; United States; Zanamivir | 2007 |
Chinese medicinal herbs for influenza.
Topics: Amantadine; Antiviral Agents; Drugs, Chinese Herbal; Humans; Influenza, Human; Phytotherapy; Randomized Controlled Trials as Topic; Ribavirin | 2007 |
Antiviral therapy. Respiratory infections, genital herpes, and herpetic keratitis.
Topics: Acyclovir; Adult; Amantadine; Antiviral Agents; Child; Female; Herpes Genitalis; Humans; Idoxuridine; Infant; Infant, Newborn; Influenza, Human; Keratitis, Dendritic; Male; Picornaviridae Infections; Recurrence; Respiratory Syncytial Viruses; Respiratory Tract Infections; Respirovirus Infections; Rhinovirus; Ribavirin; Rimantadine; Trifluridine; Vidarabine | 1984 |
Antiviral drugs 1983.
Topics: Acyclovir; Amantadine; Antiviral Agents; Clinical Trials as Topic; Female; Herpes Genitalis; Herpes Simplex; Humans; Idoxuridine; Influenza, Human; Interferons; Keratitis, Dendritic; Male; Ribavirin; Rimantadine; Trifluridine; Vidarabine | 1983 |
Antivirals for pandemic influenza.
Topics: Amantadine; Antiviral Agents; Humans; Influenza, Human; Neuraminidase; Ribavirin; Rimantadine | 1997 |
Underused options for preventing and treating influenza.
Topics: Adolescent; Adult; Aged; Amantadine; Antiviral Agents; Child; Child, Preschool; Drug Administration Routes; Female; Guanidines; Humans; Influenza Vaccines; Influenza, Human; Male; Middle Aged; Orthomyxoviridae; Pyrans; Ribavirin; Rimantadine; Sialic Acids; Zanamivir | 1999 |
[Prophylaxis and treatment of respiratory infections caused by influenza virus types A and B].
Topics: Amantadine; Antiviral Agents; Drug Resistance, Microbial; Humans; Influenza, Human; Neuraminidase; Orthomyxoviridae; Ribavirin; Rimantadine | 1999 |
Prevention and treatment of influenza in immunocompromised patients.
Topics: Aerosols; AIDS-Related Opportunistic Infections; Amantadine; Antiviral Agents; Bone Marrow Transplantation; Drug Resistance, Microbial; Humans; Immunocompromised Host; Influenza Vaccines; Influenza, Human; Infusions, Intravenous; Organ Transplantation; Orthomyxoviridae; Primary Prevention; Ribavirin; Rimantadine | 1997 |
Antivirals with clinical potential.
Topics: Amantadine; Animals; Antiviral Agents; Cytarabine; Herpes Labialis; Herpes Simplex; Humans; Idoxuridine; Influenza, Human; Inosine Pranobex; Interferon Inducers; Interferons; Keratitis, Dendritic; Levamisole; Methisazone; Ribavirin; Smallpox; Vidarabine | 1979 |
Antiviral agents: action and clinical use.
Topics: Amantadine; Antiviral Agents; Ascorbic Acid; Cytarabine; Humans; Idoxuridine; Influenza, Human; Inosine Pranobex; Interferons; Levamisole; Methisazone; Ribavirin; Vidarabine; Virus Replication | 1979 |
[Present state of antiviral therapy (author's transl)].
Topics: Amantadine; Antiviral Agents; Child; Cytarabine; Encephalitis; Herpes Simplex; Humans; Idoxuridine; Influenza, Human; Interferons; Keratitis, Dendritic; Osteosarcoma; Ribavirin; Smallpox; Thiosemicarbazones; Vidarabine | 1979 |
Specific inhibitors of influenza virus replication as potential chemoprophylactic agents.
Topics: Adamantane; Amantadine; Animals; Antiviral Agents; DNA-Directed RNA Polymerases; Drug Resistance, Microbial; Humans; Influenza, Human; Models, Molecular; Orthomyxoviridae; Ribavirin; Virus Replication | 1975 |
Clinical applications of antiviral agents for chemophrophylaxis and therapy of respiratory viral infections.
Topics: Adult; Amantadine; Antiviral Agents; Child; Child, Preschool; Clinical Trials as Topic; Humans; Influenza A virus; Influenza B virus; Influenza, Human; Interferons; Middle Aged; Picornaviridae Infections; Respiratory Tract Infections; Respirovirus Infections; Rhinovirus; Ribavirin; Rimantadine; Virus Diseases | 1985 |
Chemotherapy of respiratory viruses.
Topics: Acyclovir; Adult; Amantadine; Animals; Antiviral Agents; Benzimidazoles; Child; Clinical Trials as Topic; Female; Humans; Influenza, Human; Interferons; Oximes; Pneumonia, Viral; Respiratory Tract Infections; Ribavirin; Rimantadine; Sulfonamides; Vidarabine; Virus Diseases | 1986 |
Respiratory pharmacology. Antiviral agents.
Topics: Acyclovir; Amantadine; Antiviral Agents; Ganciclovir; Herpesviridae Infections; Humans; Influenza, Human; Interferons; Ribavirin; Rimantadine; Vidarabine | 1986 |
Biochemistry and clinical applications of ribavirin.
Topics: Adult; Aerosols; Animals; Antiviral Agents; Clinical Trials as Topic; Double-Blind Method; Humans; IMP Dehydrogenase; Infant; Infant, Newborn; Influenza, Human; Kinetics; Measles; Orthomyxoviridae; Paramyxoviridae Infections; Random Allocation; Respiratory Syncytial Viruses; Respirovirus Infections; Ribavirin; Ribonucleosides; RNA, Messenger; RNA, Viral | 1986 |
Ribavirin: a clinical overview.
Topics: Clinical Trials as Topic; Hepatitis, Viral, Human; Herpesviridae Infections; Humans; Influenza, Human; Kinetics; Lassa Fever; Measles; Respiratory Syncytial Viruses; Respirovirus Infections; Ribavirin; Ribonucleosides; Virus Diseases | 1986 |
Ribavirin aerosol treatment of influenza.
Topics: Administration, Inhalation; Adolescent; Adult; Aerosols; Humans; Infant; Influenza, Human; Ribavirin; Ribonucleosides | 1987 |
Clinical considerations in the diagnosis of viral respiratory infections.
Topics: Amantadine; Antibodies, Monoclonal; Antigens, Viral; Cross Infection; Humans; Influenza A virus; Influenza, Human; Respiratory Syncytial Viruses; Respiratory Tract Infections; Respirovirus Infections; Ribavirin; Risk; Virus Diseases | 1986 |
Influenza--recent developments in prophylaxis and treatment.
Topics: Acetylmuramyl-Alanyl-Isoglutamine; Administration, Oral; Aerosols; Amantadine; Humans; Influenza, Human; Interferon Type I; Phosphatidylethanolamines; Ribavirin; Rimantadine | 1985 |
25 trial(s) available for ribavirin and Grippe
Article | Year |
---|---|
Oseltamivir, amantadine, and ribavirin combination antiviral therapy versus oseltamivir monotherapy for the treatment of influenza: a multicentre, double-blind, randomised phase 2 trial.
Topics: Amantadine; Antiviral Agents; Argentina; Australia; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Influenza, Human; Male; Mexico; Oseltamivir; Ribavirin; Thailand; United States | 2017 |
Combination therapy with amantadine, oseltamivir and ribavirin for influenza A infection: safety and pharmacokinetics.
Topics: Adult; Amantadine; Drug Resistance, Viral; Drug Therapy, Combination; Female; Humans; Immunocompromised Host; Influenza A virus; Influenza, Human; Male; Mutation; Oseltamivir; Pilot Projects; Ribavirin; Viral Load; Young Adult | 2013 |
Ribavirin small-particle aerosol treatment of influenza.
Topics: Administration, Oral; Adult; Aerosols; Amantadine; Clinical Trials as Topic; Disease Outbreaks; Humans; Influenza, Human; Particle Size; Random Allocation; Respiratory Therapy; Ribavirin; Ribonucleosides | 1981 |
Antiviral drugs 1983.
Topics: Acyclovir; Amantadine; Antiviral Agents; Clinical Trials as Topic; Female; Herpes Genitalis; Herpes Simplex; Humans; Idoxuridine; Influenza, Human; Interferons; Keratitis, Dendritic; Male; Ribavirin; Rimantadine; Trifluridine; Vidarabine | 1983 |
Ribavirin aerosol treatment of influenza B virus infection.
Topics: Adult; Aerosols; Antibodies, Viral; Clinical Trials as Topic; Female; Humans; Influenza, Human; Male; Nasal Mucosa; Orthomyxoviridae; Random Allocation; Ribavirin; Ribonucleosides; Sodium Chloride | 1983 |
Treatment of influenza A (H1N1) virus infection with ribavirin aerosol.
Topics: Aerosols; Hemagglutination Inhibition Tests; Humans; Influenza A virus; Influenza A Virus, H1N1 Subtype; Influenza, Human; Microbial Sensitivity Tests; Ribavirin; Ribonucleosides | 1984 |
Flu trial with aerosol antiviral held promising.
Topics: Aerosols; Clinical Trials as Topic; Humans; Influenza A virus; Influenza, Human; Male; Middle Aged; Pneumonia, Viral; Ribavirin; Ribonucleosides | 1982 |
Lack of effect of oral ribavirin in naturally occurring influenza A virus (H1N1) infection.
Topics: Administration, Oral; Bilirubin; Complement Fixation Tests; Double-Blind Method; Erythrocyte Count; Hemagglutination Inhibition Tests; Hematocrit; Hemoglobins; Humans; Influenza A virus; Influenza A Virus, H1N1 Subtype; Influenza, Human; Leukocyte Count; Male; Placebos; Platelet Count; Ribavirin; Ribonucleosides; Uric Acid | 1980 |
Efficacy and safety of aerosolized ribavirin in young children hospitalized with influenza: a double-blind, multicenter, placebo-controlled trial.
Topics: Acetaminophen; Administration, Inhalation; Antibodies, Viral; Child, Preschool; Double-Blind Method; Fever; Hospitalization; Humans; Infant; Influenza A virus; Influenza B virus; Influenza, Human; Ribavirin; Treatment Outcome | 1994 |
Intravenous ribavirin by constant infusion for serious influenza and parainfluenzavirus infection.
Topics: Adult; Antiviral Agents; Bronchi; Female; Humans; Influenza, Human; Infusions, Intravenous; Male; Middle Aged; Orthomyxoviridae; Parainfluenza Virus 2, Human; Paramyxoviridae Infections; Ribavirin; Trachea | 1996 |
Clinical evaluation of 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (ribavirin) in a double-blind study during an outbreak of influenza.
Topics: Adolescent; Child; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Influenza, Human; Ribavirin; Ribonucleosides | 1977 |
Double-blind clinical assessment of ribavirin (virazole) in the prevention of induced infection with type B influenza virus.
Topics: Adult; Antibodies, Viral; Clinical Trials as Topic; Humans; Influenza A virus; Influenza, Human; Male; Middle Aged; Nasal Mucosa; Orthomyxoviridae; Placebos; Ribavirin; Ribonucleosides | 1976 |
Comparative clinical and laboratory evaluation of the prophylactic capacity of ribavirin, amantadine hydrochloride, and placebo in induced human influenza type A.
Topics: Adult; Amantadine; Antibodies, Viral; Bilirubin; Body Temperature; Clinical Trials as Topic; Humans; Influenza A virus; Influenza, Human; Male; Orthomyxoviridae; Placebos; Ribavirin; Ribonucleosides | 1976 |
Double-blind evaluation of oral ribavirin (Virazole) in experimental influenza A virus infection in volunteers.
Topics: Adult; Antibodies, Viral; Double-Blind Method; Fever; Humans; Influenza A virus; Influenza, Human; Male; Ribavirin; Ribonucleosides; Time Factors | 1977 |
Clinical applications of antiviral agents for chemophrophylaxis and therapy of respiratory viral infections.
Topics: Adult; Amantadine; Antiviral Agents; Child; Child, Preschool; Clinical Trials as Topic; Humans; Influenza A virus; Influenza B virus; Influenza, Human; Interferons; Middle Aged; Picornaviridae Infections; Respiratory Tract Infections; Respirovirus Infections; Rhinovirus; Ribavirin; Rimantadine; Virus Diseases | 1985 |
Chemotherapy of respiratory viruses.
Topics: Acyclovir; Adult; Amantadine; Animals; Antiviral Agents; Benzimidazoles; Child; Clinical Trials as Topic; Female; Humans; Influenza, Human; Interferons; Oximes; Pneumonia, Viral; Respiratory Tract Infections; Ribavirin; Rimantadine; Sulfonamides; Vidarabine; Virus Diseases | 1986 |
Comparison of oral and aerosol ribavirin regimens in the high risk elderly.
Topics: Administration, Inhalation; Administration, Oral; Aged; Clinical Trials as Topic; Drug Administration Schedule; Female; Humans; Influenza, Human; Male; Middle Aged; Radioimmunoassay; Ribavirin; Ribonucleosides; Risk Factors; Time Factors | 1989 |
Biochemistry and clinical applications of ribavirin.
Topics: Adult; Aerosols; Animals; Antiviral Agents; Clinical Trials as Topic; Double-Blind Method; Humans; IMP Dehydrogenase; Infant; Infant, Newborn; Influenza, Human; Kinetics; Measles; Orthomyxoviridae; Paramyxoviridae Infections; Random Allocation; Respiratory Syncytial Viruses; Respirovirus Infections; Ribavirin; Ribonucleosides; RNA, Messenger; RNA, Viral | 1986 |
[New therapeutic strategies in influenza infections in patients at risk. Controlled study of ribavirin].
Topics: Aged; Aged, 80 and over; Anemia; Clinical Trials as Topic; Double-Blind Method; Humans; Influenza, Human; Middle Aged; Random Allocation; Ribavirin; Ribonucleosides; Risk Factors | 1987 |
Antiviral chemotherapy and chemoprophylaxis.
Topics: Acyclovir; Adult; Aged; Amantadine; Antiviral Agents; Chickenpox; Clinical Trials as Topic; Cytomegalovirus; Encephalitis; Foscarnet; Guanosine Triphosphate; Herpes Simplex; Herpes Zoster; Herpesviridae Infections; Humans; Infant, Newborn; Infant, Newborn, Diseases; Influenza A virus; Influenza, Human; Phosphonoacetic Acid; Respiratory Tract Infections; Ribavirin; Rimantadine; Vidarabine; Virus Diseases | 1985 |
Ribavirin: a clinical overview.
Topics: Clinical Trials as Topic; Hepatitis, Viral, Human; Herpesviridae Infections; Humans; Influenza, Human; Kinetics; Lassa Fever; Measles; Respiratory Syncytial Viruses; Respirovirus Infections; Ribavirin; Ribonucleosides; Virus Diseases | 1986 |
Ribavirin small-particle-aerosol treatment of influenza B virus infection.
Topics: Adult; Aerosols; Body Temperature; Clinical Trials as Topic; Disease Outbreaks; Double-Blind Method; Humans; Influenza B virus; Influenza, Human; Random Allocation; Ribavirin; Ribonucleosides | 1988 |
Oral ribavirin treatment of influenza A and B.
Topics: Administration, Oral; Adult; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Influenza A virus; Influenza B virus; Influenza, Human; Male; Middle Aged; Random Allocation; Ribavirin; Ribonucleosides; Time Factors | 1987 |
Ribavirin small-particle aerosol treatment of infections caused by influenza virus strains A/Victoria/7/83 (H1N1) and B/Texas/1/84.
Topics: Aerosols; Clinical Trials as Topic; Double-Blind Method; Female; Hemagglutination Inhibition Tests; Hematocrit; Humans; Influenza A virus; Influenza A Virus, H1N1 Subtype; Influenza B virus; Influenza, Human; Leukocyte Count; Male; Random Allocation; Ribavirin; Ribonucleosides | 1985 |
[Clinical study of the antiviral preparation ML-76 in influenza].
Topics: Adolescent; Adult; Antiviral Agents; Clinical Trials as Topic; Humans; Influenza A virus; Influenza, Human; Ribavirin; Ribonucleosides | 1985 |
60 other study(ies) available for ribavirin and Grippe
Article | Year |
---|---|
Spiro[pyrrolidine-2,2'-adamantanes]: synthesis, anti-influenza virus activity and conformational properties.
Topics: Adamantane; Antiviral Agents; Cell Line; Humans; Influenza A virus; Influenza, Human; Models, Molecular; Molecular Conformation; Nuclear Magnetic Resonance, Biomolecular; Pyrrolidines; Structure-Activity Relationship | 2003 |
Efficacy of orally administered T-705 on lethal avian influenza A (H5N1) virus infections in mice.
Topics: Amides; Animals; Antiviral Agents; Cells, Cultured; Cytopathogenic Effect, Viral; Humans; Influenza A Virus, H5N1 Subtype; Influenza, Human; Lung; Mice; Mice, Inbred BALB C; Oseltamivir; Oxygen; Pyrazines; Survival Analysis; Virus Replication | 2007 |
Synthesis and anti-influenza activities of carboxyl alkoxyalkyl esters of 4-guanidino-Neu5Ac2en (zanamivir).
Topics: Administration, Oral; Animals; Cell Line; Disease Models, Animal; Dogs; Drug Design; Humans; Influenza A virus; Influenza Vaccines; Influenza, Human; Infusions, Parenteral; Inhibitory Concentration 50; Mice; Ribavirin; Zanamivir | 2007 |
In vitro antiviral activity of favipiravir (T-705) against drug-resistant influenza and 2009 A(H1N1) viruses.
Topics: Amides; Animals; Antiviral Agents; Cell Line; Dogs; Drug Resistance, Viral; Humans; In Vitro Techniques; Influenza A virus; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H2N2 Subtype; Influenza A Virus, H5N1 Subtype; Influenza B virus; Influenza, Human; Microbial Sensitivity Tests; Pyrazines; Swine; Viral Plaque Assay; Virus Replication | 2010 |
Synthesis and anti-influenza activity of aminoalkyl rupestonates.
Topics: Amination; Animals; Antiviral Agents; Azulenes; Cell Line; Dogs; Halogenation; Humans; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H3N2 Subtype; Influenza B virus; Influenza, Human; Sesquiterpenes; Structure-Activity Relationship | 2012 |
4,6-Diphenylpyridines as Promising Novel Anti-Influenza Agents Targeting the PA-PB1 Protein-Protein Interaction: Structure-Activity Relationships Exploration with the Aid of Molecular Modeling.
Topics: Animals; Antiviral Agents; Crystallography, X-Ray; DNA-Directed RNA Polymerases; Dogs; Drug Design; HEK293 Cells; Humans; Influenza A virus; Influenza, Human; Madin Darby Canine Kidney Cells; Models, Molecular; Molecular Docking Simulation; Pyridines; Structure-Activity Relationship; Viral Plaque Assay; Viral Proteins; Virus Replication | 2016 |
Anti-influenza triterpenoid saponins (saikosaponins) from the roots of Bupleurum marginatum var. stenophyllum.
Topics: Antiviral Agents; Bupleurum; Cell Line; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Oleanolic Acid; Plant Roots; Saponins; Structure-Activity Relationship | 2017 |
Novel amides modified rupestonic acid derivatives as anti-influenza virus reagents.
Topics: Amides; Antiviral Agents; Azulenes; Crystallography, X-Ray; Humans; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H3N2 Subtype; Influenza, Human; Sesquiterpenes | 2019 |
Synthesis and structure-activity relationships of novel camphecene analogues as anti-influenza agents.
Topics: Camphor; Ethanolamines; Humans; Influenza, Human; Structure-Activity Relationship | 2019 |
Superior inhibition of influenza virus hemagglutinin-mediated fusion by indole-substituted spirothiazolidinones.
Topics: Animals; Antiviral Agents; Dogs; Dose-Response Relationship, Drug; Hemagglutinin Glycoproteins, Influenza Virus; Humans; Hydrogen-Ion Concentration; Indoles; Influenza A Virus, H3N2 Subtype; Influenza, Human; Madin Darby Canine Kidney Cells; Microbial Sensitivity Tests; Molecular Docking Simulation; Molecular Structure; Protein Refolding; Spiro Compounds; Structure-Activity Relationship; Thiazolidines | 2020 |
New type of anti-influenza agents based on benzo[d][1,3]dithiol core.
Topics: Animals; Antiviral Agents; Dogs; Hemagglutinin Glycoproteins, Influenza Virus; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Madin Darby Canine Kidney Cells; Molecular Docking Simulation; Orthomyxoviridae Infections; Toluene | 2020 |
A broad influenza virus inhibitor acting via IMP dehydrogenase and in synergism with ribavirin.
Topics: Antiviral Agents; Cell Line; Drug Synergism; Enzyme Inhibitors; Humans; IMP Dehydrogenase; Influenza A virus; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H3N2 Subtype; Influenza B virus; Influenza, Human; Ribavirin | 2021 |
Respiratory Syncytial Virus Infection Morbidity in the Elderly: Time for Repurposing of Ribavirin?
Topics: Aged; Humans; Influenza, Human; Morbidity; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus, Human; Ribavirin | 2020 |
Reduning plus ribavirin display synergistic activity against severe pneumonia induced by H1N1 influenza A virus in mice.
Topics: Animals; Drug Synergism; Drug Therapy, Combination; Drugs, Chinese Herbal; Female; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Interleukin-1beta; Interleukin-8; Lung; Mice; Mice, Inbred BALB C; NLR Family, Pyrin Domain-Containing 3 Protein; Pneumonia; Ribavirin | 2020 |
Outcomes of severe human metapneumovirus-associated community-acquired pneumonia in adults.
Topics: Administration, Oral; Aged; Community-Acquired Infections; Female; Hospitalization; Humans; Incidence; Influenza, Human; Intensive Care Units; Length of Stay; Male; Metapneumovirus; Middle Aged; Mortality; Paramyxoviridae Infections; Pneumonia, Viral; Prospective Studies; Ribavirin; Seoul | 2019 |
Antivirally active ribavirin analogues--4,5-disubstituted 1,2,3-triazole nucleosides: biological evaluation against certain respiratory viruses and computational modelling.
Topics: Animals; Antiviral Agents; Cell Line; Humans; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H3N2 Subtype; Influenza A Virus, H5N1 Subtype; Influenza B virus; Influenza, Human; Measles; Measles virus; Models, Molecular; Nucleosides; Orthomyxoviridae Infections; Parainfluenza Virus 3, Human; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Respirovirus Infections; Ribavirin; Triazoles | 2014 |
Virological clearance rate of high-dose oseltamivir or triple-combination antiviral therapy in complicated 2009 pandemic influenza A (H1N1) infection.
Topics: Adolescent; Adult; Aged; Amantadine; Antiviral Agents; Drug Therapy, Combination; Female; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Middle Aged; Oseltamivir; Respiratory Distress Syndrome; Ribavirin; Survival Analysis; Treatment Outcome | 2013 |
Anti-influenza virus effects of crude phenylethanoid glycosides isolated from ligustrum purpurascens via inducing endogenous interferon-γ.
Topics: Animals; Antiviral Agents; Cytokines; Dogs; Female; Glycosides; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Interferon Inducers; Interferon-gamma; Ligustrum; Lung; Lymphocyte Count; Madin Darby Canine Kidney Cells; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Pulmonary Edema; Ribavirin; Survival Analysis | 2016 |
Antiviral activity of SA-2 against influenza A virus in vitro/vivo and its inhibition of RNA polymerase.
Topics: A549 Cells; Acute Lung Injury; Animals; Antiviral Agents; Benzoates; DNA-Directed RNA Polymerases; Dogs; Drug Evaluation, Preclinical; Drug Resistance, Viral; HEK293 Cells; Humans; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H3N2 Subtype; Influenza, Human; Madin Darby Canine Kidney Cells; Male; Mice; Mice, Inbred ICR; Orthomyxoviridae Infections; Oseltamivir; Ribavirin; Virus Replication | 2016 |
Combination of ribavirin and reduning protects mice against severe pneumonia induced by H1N1 influenza a virus.
Topics: Animals; Antiviral Agents; Drug Synergism; Drug Therapy, Combination; Drugs, Chinese Herbal; Female; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Interleukin-10; Interleukin-6; Mice; Mice, Inbred C57BL; Pneumonia; Ribavirin | 2016 |
Macromolecular Prodrugs of Ribavirin: Structure-Function Correlation as Inhibitors of Influenza Infectivity.
Topics: A549 Cells; Animals; Antiviral Agents; Cell Line; Cell Line, Tumor; Chlorocebus aethiops; Humans; Influenza A virus; Influenza, Human; Macromolecular Substances; Polymers; Prodrugs; Ribavirin; Simplexvirus; Structure-Activity Relationship; Vero Cells | 2017 |
Cryptoporic acid E from Cryptoporus volvatus inhibits influenza virus replication in vitro.
Topics: Animals; Antiviral Agents; Cell Survival; DNA-Directed RNA Polymerases; Dogs; Humans; In Vitro Techniques; Influenza A virus; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H3N2 Subtype; Influenza, Human; Inhibitory Concentration 50; Lung; Madin Darby Canine Kidney Cells; Mice; Orthomyxoviridae Infections; Polyporaceae; Ribavirin; RNA, Viral; Sesquiterpenes; Virion; Virus Replication | 2017 |
Augmented lung inflammation protects against influenza A pneumonia.
Topics: Adjuvants, Immunologic; Administration, Inhalation; Animals; Antiviral Agents; Gene Expression; Haemophilus Infections; Haemophilus influenzae; Humans; Immunity, Innate; Influenza A virus; Influenza, Human; Interferons; Lung; Mice; Pneumonia; Pneumonia, Bacterial; Ribavirin; Signal Transduction | 2009 |
Evidence-based antimicrobial therapy in pregnancy: long overdue.
Topics: Adult; Anti-Infective Agents; Antiviral Agents; Evidence-Based Medicine; Female; Hepatitis C; Humans; Influenza, Human; Pregnancy; Pregnancy Complications, Infectious; Ribavirin; United States; United States Food and Drug Administration | 2009 |
Use of ribavirin to treat influenza.
Topics: Administration, Inhalation; Administration, Oral; Antiviral Agents; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Randomized Controlled Trials as Topic; Ribavirin | 2009 |
[Investigation of susceptibility of influenza viruses A (H1N1), the cause of infection in humans in April-May 2009, to antivirals in MDCK cell culture].
Topics: Amino Acid Substitution; Animals; Antiviral Agents; Cell Line; Dogs; Drug Resistance, Viral; Genome, Viral; Humans; Indoles; Influenza A Virus, H1N1 Subtype; Influenza, Human; Mutation, Missense; Ribavirin; Viral Matrix Proteins; Virus Replication | 2009 |
T-705 (favipiravir) activity against lethal H5N1 influenza A viruses.
Topics: Aged; Amides; Animals; Antiviral Agents; Cell Line; Child; DNA Replication; DNA-Directed DNA Polymerase; Dogs; Drug Resistance, Viral; Humans; Influenza A Virus, H5N1 Subtype; Influenza, Human; Kidney; Kinetics; Lung; Oseltamivir; Pyrazines; Ribavirin | 2010 |
Fatal avian influenza (H5N1) infection in Human, China.
Topics: Adult; Animals; Antiviral Agents; Birds; Fatal Outcome; Female; Genome, Viral; Humans; Influenza A Virus, H5N1 Subtype; Influenza, Human; Multiple Organ Failure; Respiratory Distress Syndrome; Ribavirin | 2010 |
The persistence of influenza infection.
Topics: Antiviral Agents; Child, Preschool; Feces; Humans; Immunocompromised Host; Influenza, Human; Male; Mucus; Respiratory System; Ribavirin | 2010 |
[Susceptibility of pandemic influenza virus A 2009 H1N1 and highly pathogenic avian influenza virus A H5N1 to antiinfluenza agents in cell culture].
Topics: Animals; Antiviral Agents; Birds; Cell Line; Drug Resistance, Viral; Humans; Indoles; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H5N1 Subtype; Influenza in Birds; Influenza, Human; Oseltamivir; Ribavirin; Rimantadine; Virus Replication | 2011 |
Triple-combination antiviral drug for pandemic H1N1 influenza virus infection in critically ill patients on mechanical ventilation.
Topics: Adult; Aged; Aged, 80 and over; Amantadine; Antiviral Agents; Cohort Studies; Critical Illness; Drug Therapy, Combination; Female; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Korea; Male; Middle Aged; Oseltamivir; Pandemics; Respiration, Artificial; Retrospective Studies; Ribavirin; Treatment Outcome | 2011 |
Severe anaemia related to oseltamivir during treatment of chronic hepatitis C: a new drug interaction?
Topics: Adult; Anemia; Antiviral Agents; Drug Interactions; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Interferon alpha-2; Interferon-alpha; Oseltamivir; Polyethylene Glycols; Recombinant Proteins; Ribavirin | 2012 |
Low mortality rates related to respiratory virus infections after bone marrow transplantation.
Topics: Acetamides; Aerosols; Antigens, Viral; Antiviral Agents; Bone Marrow Transplantation; Fluorescent Antibody Technique, Indirect; Hematologic Neoplasms; Humans; Influenza, Human; Oseltamivir; Paramyxoviridae Infections; Postoperative Complications; Respirovirus Infections; Ribavirin; Transplantation, Autologous; Transplantation, Homologous; Virus Shedding | 2003 |
[Sensitivity of various influenza virus strains to arbidol. Influence of arbidol combination with different antiviral drugs on reproduction of influenza virus A].
Topics: Amantadine; Animals; Antiviral Agents; Dogs; Drug Therapy, Combination; Embryo, Mammalian; Indoles; Influenza A virus; Influenza B virus; Influenza, Human; Microbial Sensitivity Tests; Ribavirin; Virus Replication | 2005 |
Anti-RNA virus activity of polyoxometalates.
Topics: Animals; Antiviral Agents; Coronavirus; Drug Resistance, Viral; Drug Synergism; Humans; Influenza, Human; Orthomyxoviridae; Ribavirin; RNA Viruses; Titanium; Tungsten Compounds; Vanadium Compounds; Virus Diseases | 2006 |
MegaRibavirin aerosol for the treatment of influenza A virus infections in mice.
Topics: Aerosols; Animals; Antiviral Agents; Disease Models, Animal; Female; Humans; Influenza A Virus, H3N2 Subtype; Influenza, Human; Mice; Nebulizers and Vaporizers; Orthomyxoviridae Infections; Ribavirin; Treatment Outcome | 2008 |
Obtaining of a virazole-resistant fowl plague virus mutant.
Topics: Animals; Birds; Drug Resistance; Humans; Influenza A virus; Influenza in Birds; Influenza, Human; Mutation; Phenotype; Ribavirin; Ribonucleosides | 1982 |
Ribavirin for influenza and respiratory syncytial virus infections.
Topics: Aerosols; Double-Blind Method; Humans; Influenza, Human; Respiratory Syncytial Viruses; Respirovirus Infections; Ribavirin; Ribonucleosides | 1983 |
Increasing experience for the evaluation of antiviral chemotherapy.
Topics: Adult; Amantadine; Animals; Antiviral Agents; Drug Therapy; Humans; Influenza, Human; Interferons; Ribavirin; Virus Replication | 1980 |
Ribavirin.
Topics: Adult; Humans; Infant; Influenza, Human; Respiratory Syncytial Viruses; Respirovirus Infections; Ribavirin; Ribonucleosides; Virus Diseases | 1984 |
Prospects for broad-spectrum chemotherapy of serious viral respiratory infections.
Topics: Aerosols; Humans; Influenza, Human; Respiratory Syncytial Viruses; Respiratory Tract Infections; Respirovirus Infections; Ribavirin; Ribonucleosides | 1983 |
Comparative activity of amantadine and ribavirin against influenza virus in vitro: possible clinical relevance.
Topics: Amantadine; Animals; Dogs; Humans; Influenza, Human; Microbial Sensitivity Tests; Orthomyxoviridae; Ribavirin; Ribonucleosides | 1983 |
Plaque inhibition assay for drug susceptibility testing of influenza viruses.
Topics: Amantadine; Antiviral Agents; Drug Resistance, Microbial; Humans; Influenza, Human; Microbial Sensitivity Tests; Orthomyxoviridae; Ribavirin; Rimantadine; Time Factors; Viral Plaque Assay | 1980 |
Combination antiviral therapy for respiratory virus infections.
Topics: Amantadine; Animals; Antiviral Agents; Common Cold; Drug Therapy, Combination; Humans; Influenza, Human; Respiratory Syncytial Virus Infections; Respiratory Tract Infections; Ribavirin; Rimantadine | 1996 |
Ribavirin therapy in bone marrow transplant recipients with viral respiratory tract infections.
Topics: Administration, Oral; Adult; Antiviral Agents; Bone Marrow Transplantation; Child; Child, Preschool; Female; Graft Rejection; Humans; Immunosuppressive Agents; Infant; Influenza B virus; Influenza, Human; Injections, Intravenous; Male; Middle Aged; Parainfluenza Virus 1, Human; Respiratory Syncytial Virus Infections; Respirovirus Infections; Ribavirin; Transplantation, Autologous; Transplantation, Homologous | 1997 |
Inhibition of influenza virus infections in mice by GS4104, an orally effective influenza virus neuraminidase inhibitor.
Topics: Acetamides; Administration, Intranasal; Administration, Oral; Amines; Animals; Antiviral Agents; Cell Line; Disease Models, Animal; Dogs; Enzyme Inhibitors; Female; Guanidines; Humans; Influenza A virus; Influenza B virus; Influenza, Human; Lung Diseases; Mice; Mice, Inbred BALB C; Molecular Structure; Neuraminidase; Oseltamivir; Pyrans; Ribavirin; Sialic Acids; Zanamivir | 1998 |
Apoptosis in cultured human fetal membrane cells infected with influenza virus.
Topics: Antiviral Agents; Apoptosis; Cells, Cultured; Chorion; Cytopathogenic Effect, Viral; DNA Fragmentation; Extraembryonic Membranes; Female; Humans; Influenza A virus; Influenza, Human; L-Lactate Dehydrogenase; Pregnancy; Ribavirin; Viral Plaque Assay; Virus Replication | 2002 |
Drugs for non-HIV viral infections.
Topics: 2-Aminopurine; Acyclovir; Administration, Oral; Administration, Topical; Amantadine; Animals; Antiviral Agents; Cidofovir; Cytosine; Famciclovir; Foscarnet; Guanine; Herpesviridae Infections; Humans; Influenza, Human; Injections, Intravenous; Lamivudine; Organophosphonates; Organophosphorus Compounds; Rats; Ribavirin; Rimantadine; Thionucleotides; Trifluridine; Valacyclovir; Valine | 2002 |
Antiviral agents.
Topics: Amantadine; Antiviral Agents; Humans; Idoxuridine; Influenza, Human; Methisazone; Ribavirin; Vidarabine | 1977 |
Antiviral agents in influenza--summary of Influenza Workshop VIII.
Topics: Amantadine; Animals; Antiviral Agents; Drug Evaluation; Humans; Influenza, Human; Interferon Inducers; Interferons; Neuraminidase; Pneumonia; Pneumonia, Viral; Ribavirin; Terpenes; Vaccination; Viral Interference | 1976 |
Antivirals for the chemoprophylaxis and treatment of influenza.
Topics: Administration, Intranasal; Administration, Oral; Amantadine; Drug Resistance; Humans; Influenza A virus; Influenza B virus; Influenza, Human; Ribavirin; Rimantadine | 1992 |
Hemodialysis clearance of intravenously administered ribavirin.
Topics: Adult; Female; Heart, Artificial; Humans; Influenza A virus; Influenza, Human; Injections, Intravenous; Renal Dialysis; Ribavirin; Ribonucleosides | 1990 |
Antiviral therapy. New drugs and their uses.
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Amantadine; Antiviral Agents; Chickenpox; Common Cold; Cytomegalovirus Infections; Herpes Simplex; Herpes Zoster; Herpesviridae Infections; Herpesvirus 4, Human; Humans; Influenza, Human; Interferons; Ribavirin; Rimantadine; Thymidine; Vidarabine; Virus Diseases; Zidovudine | 1986 |
Antiviral drugs for common respiratory diseases. What's here, what's to come.
Topics: Adult; Aged; Amantadine; Antiviral Agents; Child; Female; Humans; Infant; Infant, Newborn; Influenza, Human; Interferons; Paramyxoviridae Infections; Pneumonia, Viral; Pregnancy; Respiratory Syncytial Viruses; Respiratory Tract Infections; Respirovirus Infections; Ribavirin; Rimantadine; Virus Diseases | 1988 |
Influenza B in transplant patients.
Topics: Adult; Bone Marrow Transplantation; Child; Female; Humans; Influenza B virus; Influenza, Human; Kidney Transplantation; Male; Middle Aged; Postoperative Complications; Ribavirin; Ribonucleosides | 1989 |
The use of intravenous ribavirin to treat influenza virus-associated acute myocarditis.
Topics: Acute Disease; Adult; Child, Preschool; Female; Humans; Influenza A virus; Influenza B virus; Influenza, Human; Infusions, Intravenous; Myocarditis; Myocardium; Ribavirin; Ribonucleosides | 1989 |
Nebulised ribavirin for influenza B viral pneumonia in a ventilated immunocompromised adult.
Topics: Humans; Immune Tolerance; Influenza B virus; Influenza, Human; Male; Middle Aged; Nebulizers and Vaporizers; Pneumonia, Viral; Respiration, Artificial; Ribavirin; Ribonucleosides | 1988 |
Favorable outcome after treatment with amantadine and ribavirin in a pregnancy complicated by influenza pneumonia. A case report.
Topics: Adult; Amantadine; Drug Therapy, Combination; Female; Humans; Infant, Newborn; Influenza A virus; Influenza, Human; Pneumonia, Viral; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Ribavirin; Ribonucleosides | 1988 |
Antiviral agents.
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Amantadine; Antiviral Agents; Ganciclovir; Herpes Simplex; Humans; Idoxuridine; Influenza A virus; Influenza, Human; Ribavirin; Rimantadine; Thymidine; Vidarabine; Viruses; Zidovudine | 1987 |
Ribavirin (virazole): a novel antiviral agent against viral respiratory tract infections.
Topics: Child; Humans; Influenza, Human; Respiratory Syncytial Viruses; Respiratory Tract Infections; Respirovirus Infections; Ribavirin; Ribonucleosides | 1986 |